OcuSciences

OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.

OcuSciences is a medical diagnostic device company developing an ocular imaging technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction. The company is focused on the investigation of ocular manifestations of diabetes and therapies aimed at treating them. The technique, termed Retinal Metabolic Analysis (RMA), is designed to detect retinal diseases such as diabetic retinopathy, macular degeneration, and glaucoma, before irreversible cell death becomes visible. The device, OcuMet Beacon, is designed to provide a fundus, back of the eye, photograph and using the RMA technology, provide a metabolic signature of the health of retinal cells. OcuSciences was founded in 2008 and is based in Ann Arbor, Michigan.